FAKTOR OPTIONSSCHEIN - MERCK & CO. | Market Closed - Börse Stuttgart 01:20:32 29/06/2024 am IST | ||
| 8.8 EUR | +9.32% |
|
| Current month | -5.58% | ||
| 1 month | -4.45% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 28/24/28 | 8.8 | +9.32% |
| 27/24/27 | 8.05 | +6.06% |
| 26/24/26 | 7.59 | +3.27% |
| 25/24/25 | 7.35 | +1.10% |
| 24/24/24 | 7.27 | -8.21% |
Delayed Quote Börse Stuttgart
Last update June 29, 2024 at 01:20 am IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | UBS |
| WKN | UM3R2F |
| ISIN | DE000UM3R2F0 |
| Date issued | 28/03/2024 |
| Strike | 162.3 $ |
| Maturity | Unlimited |
| Parity | 3.75 : 1 |
| Emission price | 9.93 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 9.93 € |
|---|---|
| Lowest since issue | 7.18 € |
| Spread | 0.1 € |
| Spread % | 1.11% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
123.8
USD
Average target price
142.7
USD
Spread / Average Target
+15.25%
- Stock Market
- Certificates
- Certificat
